未登录

M

Masato Tashiro

who collaborating centre for influenza

H指数:61

被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dr. Nancy Jane Cox, PhD (1948–2026)

Nancy Jane Cox博士（1948–2026）

Influenza and Other Respiratory Viruses

IF4.2

2026-08-190

OAAI

Evaluation of Immunogenicity of Seasonal Influenza Split HA Vaccines Involved With Changes of Vaccine Strains Using Mouse and Human Sera

Microbiology and Immunology

IF1.8

2025-10-010

OAAI

Comparison of suspension MDCK cells, adherent MDCK cells, and LLC-MK2 cells for selective isolation of influenza viruses to be used as vaccine seeds

悬浮MDCK细胞、贴壁MDCK细胞和LLC-MK2细胞选择性隔离用作疫苗种子的流感病毒的比较

INFLUENZA AND OTHER RESPIRATORY VIRUSES

IF4.2

2019-10-256

OAAI

A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines (vol 7, 1283, 2017)

SCIENTIFIC REPORTS

IF3.9

2019-10-082

OAAI

Efficient protection of mice from influenza A/H1N1pdm09 virus challenge infection via high avidity serum antibodies induced by booster immunizations with inactivated whole virus vaccine

通过灭活全病毒疫苗加强免疫诱导的高亲和力血清抗体有效保护小鼠免受甲型H1N1pdm09流感病毒攻击感染

IF3.6

2019-01-016

OAAI

IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2018-04-0943

OAAI

A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines

SCIENTIFIC REPORTS

IF3.9

2017-04-2836

OAAI

Generation of a Genetically Stable HighFidelity Influenza Vaccine Strain

JOURNAL OF VIROLOGY

IF3.8

2017-03-1519

OA

TMPRSS2 Independency for Haemagglutinin Cleavage In Vivo Differentiates Influenza B Virus from Influenza A Virus

体内血凝素裂解的TMPRSS2独立性将乙型流感病毒与甲型流感病毒区分开

SCIENTIFIC REPORTS

IF3.9

2016-07-0816

OAAI

Whole-Virion Influenza Vaccine Recalls an Early Burst of High-Affinity Memory B Cell Response through TLR Signaling

JOURNAL OF IMMUNOLOGY

IF3.4

2016-05-1534

OAAI

A Novel Potent and Highly Specific Inhibitor against Influenza Viral N1-N9 Neuraminidases: Insight into Neuraminidase-Inhibitor Interactions

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2016-05-0425

PREAI

Novel Reassortant Avian Influenza A(H5N1) Virus in Human, Southern Vietnam, 2014

EMERGING INFECTIOUS DISEASES

IF6.6

2016-03-016

OAAI

Structural and computational study on inhibitory compounds for endonuclease activity of influenza virus polymerase

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2015-09-0128

PREAI

Relationship of the quaternary structure of human secretory IgA to neutralization of influenza virus

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2015-06-08108

OAAI

Characterization of a Large Cluster of Influenza A(H1N1)pdm09 Viruses Cross-Resistant to Oseltamivir and Peramivir during the 2013-2014 Influenza Season in Japan

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2015-05-0168

OAAI

A Mutant H3N2 Influenza Virus Uses an Alternative Activation Mechanism in TMPRSS2 Knockout Mice by Loss of an Oligosaccharide in the Hemagglutinin Stalk Region

JOURNAL OF VIROLOGY

IF3.8

2015-05-0130

OAAI

Molecular evolution of the VP1, VP2, and VP3 genes in human rhinovirus species C

SCIENTIFIC REPORTS

IF3.9

2015-02-0220

OAAI

Influenza Gain-of-Function Experiments: Their Role in Vaccine Virus Recommendation and Pandemic Preparedness

IF4.7

2014-12-3125

OAAI

Epitope Mapping of the Hemagglutinin Molecule of A/(H1N1)pdm09 Influenza Virus by Using Monoclonal Antibody Escape Mutants

JOURNAL OF VIROLOGY

IF3.8

2014-11-0181

OAAI

Intranasal vaccination with an inactivated whole influenza virus vaccine induces strong antibody responses in serum and nasal mucus of healthy adults

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2014-10-2767

OAAI